Literature DB >> 26005678

The generation of carcinogenic etheno-DNA adducts in the liver of patients with nonalcoholic fatty liver disease.

Kirsten-Berit Linhart1, Katharina Glassen1, Teresa Peccerella1, Rüdiger Waldherr1, Heinz Linhart1, Helmut Bartsch1, Helmut K Seitz1.   

Abstract

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD), in particular its more aggressive form nonalcoholic steatohepatitis (NASH) is increasingly observed as a cause of end stage liver disease and hepatocellular carcinoma (HCC). Reactive oxygen species (ROS) are an important factor in the pathogenesis of HCC. ROS can react with polyunsaturated fatty acids derived from membrane phospholipids resulting in the production of reactive aldehydes as lipid oxidation (LPO) byproducts, such as 4-hydroxynonenal (4 HNE). 4 HNE can react with DNA to form mutagenic exocyclic etheno-DNA adducts. ROS is induced by inflammatory processes, but also by induction of cytochrome P450 2E1 (CYP2E1), as seen with chronic alcohol consumption.
METHODS: Immunohistochemical detection of CYP2E1, 4 HNE and hepatic exocyclic etheno-DNA adducts was performed on liver sections from 39 patients with NFLD. Spearman rank correlation was calculated to examine possible correlations.
RESULTS: Exocyclic etheno-DNA adducts were detected and correlated significantly with 4 HNE, but not with CYP2E1.
CONCLUSIONS: This is the first description of highly carcinogenic exocyclic etheno-DNA adducts in NAFLD patients. We could show that exocyclic etheno-DNA adducts significantly correlated with lipid peroxidation product 4 HNE, but not with CYP2E1, implying that in NAFLD ROS generation with consecutive DNA damage is rather inflammation driven through various cytokines than by induction of CYP2E1.

Entities:  

Keywords:  Nonalcoholic fatty liver disease (NAFLD); etheno-DNA adducts; hepatocellular carcinoma (HCC)

Year:  2015        PMID: 26005678      PMCID: PMC4405412          DOI: 10.3978/j.issn.2304-3881.2015.01.14

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN: 2304-3881            Impact factor:   7.293


  36 in total

1.  Chronological development of elevated aminotransferases in a nonalcoholic population.

Authors:  Ayako Suzuki; Paul Angulo; James Lymp; Jennifer St Sauver; Ayako Muto; Toshihide Okada; Keith Lindor
Journal:  Hepatology       Date:  2005-01       Impact factor: 17.425

Review 2.  Nonalcoholic fatty liver disease.

Authors:  F Schaffner; H Thaler
Journal:  Prog Liver Dis       Date:  1986

3.  Quantifying etheno-DNA adducts in human tissues, white blood cells, and urine by ultrasensitive (32)P-postlabeling and immunohistochemistry.

Authors:  Jagadeesan Nair; Urmila J Nair; Xin Sun; Ying Wang; Khelifa Arab; Helmut Bartsch
Journal:  Methods Mol Biol       Date:  2011

4.  1,N6-etheno-2'-deoxyadenosine and 3,N4-etheno-2'-deoxycytidine detected by monoclonal antibodies in lung and liver DNA of rats exposed to vinyl chloride.

Authors:  G Eberle; A Barbin; R J Laib; F Ciroussel; J Thomale; H Bartsch; M F Rajewsky
Journal:  Carcinogenesis       Date:  1989-01       Impact factor: 4.944

5.  The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.

Authors:  Mustafa S Ascha; Ibrahim A Hanouneh; Rocio Lopez; Tarek Abu-Rajab Tamimi; Ariel F Feldstein; Nizar N Zein
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

Review 6.  Alcohol, oxidative stress and free radical damage.

Authors:  Emanuele Albano
Journal:  Proc Nutr Soc       Date:  2006-08       Impact factor: 6.297

7.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

8.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

Review 9.  Etheno-adduct-forming chemicals: from mutagenicity testing to tumor mutation spectra.

Authors:  A Barbin
Journal:  Mutat Res       Date:  2000-04       Impact factor: 2.433

Review 10.  Epidemiology and natural history of NAFLD and NASH.

Authors:  Janus P Ong; Zobair M Younossi
Journal:  Clin Liver Dis       Date:  2007-02       Impact factor: 6.126

View more
  14 in total

1.  Hydrogen sulfide mitigates myocardial inflammation by inhibiting nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome activation in diabetic rats.

Authors:  Qiang Jia; Shomaila Mehmood; Xiaofen Liu; Shanfeng Ma; Rui Yang
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-13

2.  TAZ-induced Cybb contributes to liver tumor formation in non-alcoholic steatohepatitis.

Authors:  Xiaobo Wang; Sharon Zeldin; Hongxue Shi; Changyu Zhu; Yoshinobu Saito; Kathleen E Corey; Stephanie A Osganian; Helen E Remotti; Elizabeth C Verna; Utpal B Pajvani; Robert F Schwabe; Ira Tabas
Journal:  J Hepatol       Date:  2021-12-11       Impact factor: 30.083

Review 3.  Redox Signaling by Reactive Electrophiles and Oxidants.

Authors:  Saba Parvez; Marcus J C Long; Jesse R Poganik; Yimon Aye
Journal:  Chem Rev       Date:  2018-08-27       Impact factor: 60.622

4.  Detection of carcinogenic etheno-DNA adducts in children and adolescents with non-alcoholic steatohepatitis (NASH).

Authors:  Ulrike Teufel; Teresa Peccerella; Guido Engelmann; Thomas Bruckner; Christa Flechtenmacher; Gunda Millonig; Felix Stickel; Georg F Hoffmann; Peter Schirmacher; Sebastian Mueller; Helmut Bartsch; Helmut K Seitz
Journal:  Hepatobiliary Surg Nutr       Date:  2015-12       Impact factor: 7.293

5.  Reactive Carbonyl Species Scavengers-Novel Therapeutic Approaches for Chronic Diseases.

Authors:  Sean S Davies; Linda S Zhang
Journal:  Curr Pharmacol Rep       Date:  2017-02-14

6.  Enzymatic bypass and the structural basis of miscoding opposite the DNA adduct 1,N2-ethenodeoxyguanosine by human DNA translesion polymerase η.

Authors:  Pratibha P Ghodke; Jyotirling R Mali; Amritraj Patra; Carmelo J Rizzo; F Peter Guengerich; Martin Egli
Journal:  J Biol Chem       Date:  2021-04-08       Impact factor: 5.157

Review 7.  Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine.

Authors:  Kívia Queiroz de Andrade; Fabiana Andréa Moura; John Marques dos Santos; Orlando Roberto Pimentel de Araújo; Juliana Célia de Farias Santos; Marília Oliveira Fonseca Goulart
Journal:  Int J Mol Sci       Date:  2015-12-18       Impact factor: 5.923

Review 8.  Nonalcoholic Lipid Accumulation and Hepatocyte Malignant Transformation.

Authors:  Juanjuan Gu; Min Yao; Dengbing Yao; Li Wang; Xuli Yang; Dengfu Yao
Journal:  J Clin Transl Hepatol       Date:  2016-06-15

9.  Albumin Binding Function: The Potential Earliest Indicator for Liver Function Damage.

Authors:  Penglei Ge; Huayu Yang; Jingfen Lu; Wenjun Liao; Shunda Du; Yingli Xu; Haifeng Xu; Haitao Zhao; Xin Lu; Xinting Sang; Shouxian Zhong; Jiefu Huang; Yilei Mao
Journal:  Gastroenterol Res Pract       Date:  2016-12-22       Impact factor: 2.260

Review 10.  Alcohol, Aldehydes, Adducts and Airways.

Authors:  Muna Sapkota; Todd A Wyatt
Journal:  Biomolecules       Date:  2015-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.